Cancer journal (Sudbury, Mass.)HumansBrain NeoplasmsImmunotherapyImmune Checkpoint InhibitorsMolecular Targeted Therapy
Role of Immunotherapy and Targeted Agents to Treat Brain Metastases.
Nicole Hajdari, David M Peereboom
Published: 202610.1097/PPO.0000000000000806
Abstract
Brain metastases are a common yet dismal complication of metastatic cancers, originating most commonly from nonsmall cell lung cancer, breast cancer, melanoma, and renal cell carcinoma. While the current standard of care for most patients involves ra…
Preview only. Read the full abstract at the source